WINTON GROUP Ltd

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1612063 LONDON, X0

Position in ALLO

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$328,972

+$33,244 QoQ

Shares Held

158,160

+30.5% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#88

of 209 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. ALLO ranks #44 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	254,408	$28,839,690
2	FTRE	Fortrea Holdings Inc.	389,155	$6,771,297
3	EXEL	Exelixis, Inc.	99,834	$5,431,967
4	TECH	BIO-TECHNE Corp	67,227	$4,749,587
5	HALO	Halozyme Therapeutics, Inc.	60,348	$4,723,437
6	VKTX	Viking Therapeutics, Inc.	90,546	$3,532,199
7	ALNY	Alnylam Pharmaceuticals, Inc.	7,880	$2,372,116
8	TRVI	Trevi Therapeutics, Inc.	106,852	$1,992,789

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$328,972	158,160	+30.5%	Shares	Sole	2026-08-07
2026-03-31	$295,728	121,200	+225.3%	Shares	Sole	2026-05-12
2023-03-31	$184,039	37,255	+6.4%	Shares	Sole	2023-05-12
2022-12-31	$220,175	35,004	+5.2%	Shares	Sole	2023-02-14
2022-09-30	$359,445	33,282	-13.9%	Shares	Sole	2022-11-10
2022-06-30	$440,587	38,648	+26.8%	Shares	Sole	2022-08-10
2022-03-31	$277,581	30,470	+24.1%	Shares	Sole	2022-05-11
2021-12-31	$366,420	24,559	-18.2%	Shares	Sole	2022-02-10
2021-09-30	$771,308	30,012	-5.2%	Shares	Sole	2021-10-28
2021-06-30	$825,849	31,666	+59.1%	Shares	Sole	2021-08-10
2021-03-31	$702,787	19,909	-11.3%	Shares	Sole	2021-07-21
2020-12-31	$566,486	22,444	-74.8%	Shares	Sole	2021-02-12
2020-09-30	$3,362,336	89,163	+65.0%	Shares	Sole	2020-10-30
2020-06-30	$2,313,992	54,040	+12.1%	Shares	Sole	2020-08-05
2020-03-31	$937,163	48,208	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.